US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine Development

The chapter discusses the US government awarding Moderna $176 million to develop an mRNA vaccine against the highly pathogenic bird flu virus H5N1, spreading among U.S. dairy cattle, as part of preparations for pandemic threats. It also explores challenges in responding to the outbreak and criticism of the public health response.